BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22053723)

  • 1. Overcoming memory T-cell responses for induction of delayed tolerance in nonhuman primates.
    Yamada Y; Boskovic S; Aoyama A; Murakami T; Putheti P; Smith RN; Ochiai T; Nadazdin O; Koyama I; Boenisch O; Najafian N; Bhasin MK; Colvin RB; Madsen JC; Strom TB; Sachs DH; Benichou G; Cosimi AB; Kawai T
    Am J Transplant; 2012 Feb; 12(2):330-40. PubMed ID: 22053723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of CD8 memory T cells for induction of tolerance of a previously transplanted kidney allograft.
    Koyama I; Nadazdin O; Boskovic S; Ochiai T; Smith RN; Sykes M; Sogawa H; Murakami T; Strom TB; Colvin RB; Sachs DH; Benichou G; Cosimi AB; Kawai T
    Am J Transplant; 2007 May; 7(5):1055-61. PubMed ID: 17286617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host alloreactive memory T cells influence tolerance to kidney allografts in nonhuman primates.
    Nadazdin O; Boskovic S; Murakami T; Tocco G; Smith RN; Colvin RB; Sachs DH; Allan J; Madsen JC; Kawai T; Cosimi AB; Benichou G
    Sci Transl Med; 2011 Jun; 3(86):86ra51. PubMed ID: 21653831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of CTLA4Ig for induction of mixed chimerism and renal allograft tolerance in nonhuman primates.
    Yamada Y; Ochiai T; Boskovic S; Nadazdin O; Oura T; Schoenfeld D; Cappetta K; Smith RN; Colvin RB; Madsen JC; Sachs DH; Benichou G; Cosimi AB; Kawai T
    Am J Transplant; 2014 Dec; 14(12):2704-12. PubMed ID: 25394378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed chimerism to induce tolerance: lessons learned from nonhuman primates.
    Murakami T; Cosimi AB; Kawai T
    Transplant Rev (Orlando); 2009 Jan; 23(1):19-24. PubMed ID: 19027614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical and clinical studies for transplant tolerance via the mixed chimerism approach.
    Sasaki H; Oura T; Spitzer TR; Chen YB; Madsen JC; Allan J; Sachs DH; Cosimi AB; Kawai T
    Hum Immunol; 2018 May; 79(5):258-265. PubMed ID: 29175110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune monitoring of transplant patients in transient mixed chimerism tolerance trials.
    Sykes M
    Hum Immunol; 2018 May; 79(5):334-342. PubMed ID: 29289741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of Mixed Chimerism-Based Transplant Tolerance.
    Zuber J; Sykes M
    Trends Immunol; 2017 Nov; 38(11):829-843. PubMed ID: 28826941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immuno-intervention for the induction of transplantation tolerance through mixed chimerism.
    Sachs DH; Sykes M; Kawai T; Cosimi AB
    Semin Immunol; 2011 Jun; 23(3):165-73. PubMed ID: 21839648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine models of transplantation tolerance through mixed chimerism: advances and roadblocks.
    Mahr B; Wekerle T
    Clin Exp Immunol; 2017 Aug; 189(2):181-189. PubMed ID: 28395110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Memory T cells: how might they disrupt the induction of tolerance?
    Jones ND
    Transplantation; 2009 May; 87(9 Suppl):S74-7. PubMed ID: 19424014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primate models in organ transplantation.
    Anderson DJ; Kirk AD
    Cold Spring Harb Perspect Med; 2013 Sep; 3(9):a015503. PubMed ID: 24003248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance--is it worth it?
    Finger EB; Strom TB; Matas AJ
    Cold Spring Harb Perspect Med; 2014 Feb; 4(2):. PubMed ID: 24370928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current progress in xenogeneic tolerance.
    Yamada K; Scalea J
    Curr Opin Organ Transplant; 2012 Apr; 17(2):168-73. PubMed ID: 22262105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The "privileged" liver and hepatic tolerogenicity.
    Starzl TE
    Liver Transpl; 2001 Oct; 7(10):918-20. PubMed ID: 11679993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
    Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
    Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TNX-1500, a crystallizable fragment-modified anti-CD154 antibody, prolongs nonhuman primate renal allograft survival.
    Lassiter G; Otsuka R; Hirose T; Rosales I; Karadagi A; Tomosugi T; Dehnadi A; Lee H; Colvin RB; Baardsnes J; Moraitis A; Smith EE; Ali Z; Berhe P; Mulder A; Meibohm B; Daugherty B; Fogarty S; Pierson RN; Lederman S; Kawai T
    Am J Transplant; 2023 Aug; 23(8):1171-1181. PubMed ID: 37019335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chimerism-Based Tolerance to Kidney Allografts in Humans: Novel Insights and Future Perspectives.
    Podestà MA; Sykes M
    Front Immunol; 2021; 12():791725. PubMed ID: 35069574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney transplantation from triple-knockout pigs expressing multiple human proteins in cynomolgus macaques.
    Ma D; Hirose T; Lassiter G; Sasaki H; Rosales I; Coe TM; Rickert CG; Matheson R; Colvin RB; Qin W; Kan Y; Layer JV; Paragas VB; Stiede K; Hall KC; Youd ME; Queiroz LM; Westlin WF; Curtis M; Yang L; Markmann JF; Kawai T
    Am J Transplant; 2022 Jan; 22(1):46-57. PubMed ID: 34331749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Large Animal Models of Vascularized Composite Allotransplantation: A Review of Immune Strategies to Improve Allograft Outcomes.
    Matar AJ; Crepeau RL; Mundinger GS; Cetrulo CL; Torabi R
    Front Immunol; 2021; 12():664577. PubMed ID: 34276656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.